Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Rise In Air Pollution
3.2.2. High Prevalence Of Chronic Respiratory Diseases
3.2.3. Surging Indoor Air Pollutants
3.2.4. Rising Geriatric Population
3.2.5. Growing Prevalence Of Copd And Asthma
3.3. Key Restraints
3.3.1. Data Security Concern Hampers The Market
3.3.2. High Cost Of Asthma And Copd Treatment

4. Key Analytics
4.1. Porter’S Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Evolution Of Smart Inhalers
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Key Investment Insights

5. Market By Product
5.1. Smart Inhalers
5.1.1. Dry Powder Inhaler
5.1.2. Metered Dose Inhaler
5.2. Smart Nebulizer
5.2.1. Types Of Nebulizer (Qualitative)
5.2.1.1. Pneumatic Nebulizer
5.2.1.2. Ultrasonic Nebulizer
5.2.1.3. Mesh Nebulizer
5.2.2. Nebulizer By Portability (Qualitative)
5.2.2.1. Tabletop Nebulizer
5.2.2.2. Portable Nebulizer
5.2.3. Nebulizer By Sales Channel (Qualitative)
5.2.3.1. Direct Purchase
5.2.3.2. Online Purchase

6. Market By Indication
6.1. Asthma
6.2. Copd

7. Market By Distribution Channel
7.1. Hospital
7.2. Pharmacy

8. Geographical Analysis
8.1. North America
8.1.1. The United States
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. The United Kingdom
8.2.4. Italy
8.2.5. Russia
8.2.6. Belgium
8.2.7. Poland
8.2.8. Rest Of Europe
8.3. Asia Pacific
8.3.1. Japan
8.3.2. China
8.3.3. India
8.3.4. Australia & New Zealand
8.3.5. South Korea
8.3.6. Thailand
8.3.7. Indonesia
8.3.8. Vietnam
8.3.9. Rest Of Asia Pacific
8.4. Rest Of World
8.4.1. Latin America
8.4.2. Middle East & Africa

9. Company Profiles
9.1. 3M Company
9.2. Adherium Limited
9.3. Agilent Technologies Inc
9.4. Astrazeneca Plc
9.5. Boehringer Ingelheim Gmbh
9.6. Cohero Health Inc
9.7. Glaxosmithkline Plc
9.8. Koninklijke Philips N.V
9.9. Novartis Ag
9.10. Opko Health Inc
9.11. Resmed Inc (Propeller Health)
9.12. Teva Pharmaceutical Industries Limited
9.13. Vectura Group Plc



List of Figures


Figure 1: Global Population, By Age Group 2015 & 2020 (In Million)
Figure 2: Porter’S Five Force Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Key Investment Insights
Figure 6: Global Smart Inhalers Market, By Product, In 2019
Figure 7: Global Smart Inhalers Market, By Smart Inhalers, 2019-2028 (In $ Thousand)
Figure 8: Global Smart Inhalers Market, By Dry Powder Inhaler, 2019-2028 (In $ Thousand)
Figure 9: Global Smart Inhalers Market, By Metered Dose Inhaler, 2019-2028 (In $ Thousand)
Figure 10: Global Smart Inhalers Market, By Smart Nebulizer, 2019-2028 (In $ Thousand)
Figure 11: Global Smart Inhalers Market, By Indication, In 2019
Figure 12: Global Smart Inhalers Market, By Asthma, 2019-2028 (In $ Thousand)
Figure 13: Global Smart Inhalers Market, By Copd, 2019-2028 (In $ Thousand)
Figure 14: Global Smart Inhalers Market, By Distribution Channel, In 2019
Figure 15: Global Smart Inhalers Market, By Hospital, 2019-2028 (In $ Thousand)
Figure 16: Global Smart Inhalers Market, By Pharmacy, 2019-2028 (In $ Thousand)
Figure 17: North America Smart Inhalers Market, Country Outlook, 2019 & 2028 (In %)
Figure 18: The United States Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 19: Canada Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 20: Europe Smart Inhalers Market, Country Outlook, 2019 & 2028 (In %)
Figure 21: Germany Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 22: France Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 23: The United Kingdom Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 24: Italy Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 25: Russia Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 26: Belgium Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 27: Poland Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 28: Rest Of Europe Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 29: Asia Pacific Smart Inhalers Market, Country Outlook, 2019 & 2028 (In %)
Figure 30: Japan Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 31: China Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 32: India Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 33: Australia & New Zealand Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 34: South Korea Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 35: Thailand Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 36: Indonesia Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 37: Vietnam Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 38: Rest Of Asia Pacific Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 39: Rest Of World Smart Inhalers Market, Regional Outlook, 2019 & 2028 (In %)
Figure 40: Latin America Smart Inhalers Market, 2019-2028 (In $ Thousand)
Figure 41: Middle East & Africa Smart Inhalers Market, 2019-2028 (In $ Thousand)

 

List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - SMART INHALERS
TABLE 2: GLOBAL SMART INHALERS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 3: GLOBAL SMART INHALERS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 4: GLOBAL SMART INHALERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 5: GLOBAL SMART INHALERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 6: GLOBAL SMART INHALERS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 7: GLOBAL SMART INHALERS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 8: GLOBAL SMART NEBULIZER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 9: GLOBAL SMART NEBULIZER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 10: GLOBAL SMART INHALERS MARKET, BY INDICATION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 11: GLOBAL SMART INHALERS MARKET, BY INDICATION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 12: GLOBAL ASTHMA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 13: GLOBAL ASTHMA MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 14: GLOBAL COPD MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 15: GLOBAL COPD MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 16: GLOBAL SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 17: GLOBAL SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 18: GLOBAL HOSPITAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 19: GLOBAL HOSPITAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 20: GLOBAL PHARMACY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 21: GLOBAL PHARMACY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 22: GLOBAL SMART INHALERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 23: GLOBAL SMART INHALERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 24: NORTH AMERICA SMART INHALERS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 25: NORTH AMERICA SMART INHALERS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 26: EUROPE SMART INHALERS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 27: EUROPE SMART INHALERS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 28: ASIA PACIFIC SMART INHALERS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 29: ASIA PACIFIC SMART INHALERS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 30: REST OF WORLD SMART INHALERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 31: REST OF WORLD SMART INHALERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)